-
1
-
-
79958258113
-
Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a survivin-targeted, amplifiable adenoviral vector
-
Ahn BC, Ronald JA, Kim YI, Katzenberg R, Singh A, Paulmurugan R, Ray S, Hofmann LV, Gambhir SS. Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a survivin-targeted, amplifiable adenoviral vector. Gene Ther. 2011; 18: 606-612.
-
(2011)
Gene Ther.
, vol.18
, pp. 606-612
-
-
Ahn, B.C.1
Ronald, J.A.2
Kim, Y.I.3
Katzenberg, R.4
Singh, A.5
Paulmurugan, R.6
Ray, S.7
Hofmann, L.V.8
Gambhir, S.S.9
-
2
-
-
79251599238
-
Glypican-3: a new target for cancer immunotherapy
-
Ho M, Kim H. Glypican-3: a new target for cancer immunotherapy. Eur. J. Cancer 2011; 47: 333-338.
-
(2011)
Eur. J. Cancer
, vol.47
, pp. 333-338
-
-
Ho, M.1
Kim, H.2
-
3
-
-
0035086268
-
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders
-
Zhu ZW, Friess H, Wang L, Abou-Shady M, Zimmermann A, Lander AD, Korc M, Kleeff J, Buchler M. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 2001; 48: 558-564.
-
(2001)
Gut
, vol.48
, pp. 558-564
-
-
Zhu, Z.W.1
Friess, H.2
Wang, L.3
Abou-Shady, M.4
Zimmermann, A.5
Lander, A.D.6
Korc, M.7
Kleeff, J.8
Buchler, M.9
-
5
-
-
33747698690
-
Recent developments in the first detection of hepatocellular carcinoma
-
Lopez JB. Recent developments in the first detection of hepatocellular carcinoma. Clin. Biochem. Rev. 2005; 26: 65-79.
-
(2005)
Clin. Biochem. Rev.
, vol.26
, pp. 65-79
-
-
Lopez, J.B.1
-
6
-
-
5144233509
-
Identification of glypican-3 as a novel tumor marker for melanoma
-
Nakatsura T, Kageshita T, Ito S, Wakamatsu K, Monji M, Ikuta Y, Senju S, Ono T, Nishimura Y. Identification of glypican-3 as a novel tumor marker for melanoma. Clin. Cancer Res. 2004; 10: 6612-6621.
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 6612-6621
-
-
Nakatsura, T.1
Kageshita, T.2
Ito, S.3
Wakamatsu, K.4
Monji, M.5
Ikuta, Y.6
Senju, S.7
Ono, T.8
Nishimura, Y.9
-
7
-
-
38449095281
-
Glypican-3 immunocytochemistry in liver fine-needle aspirates. A novel stain to assist in the differentiation of benign and malignant liver lesions
-
Kandil D, Leiman G, Allegretta M, Trotman W, Pantanowitz L, Goulart R, Evans M. Glypican-3 immunocytochemistry in liver fine-needle aspirates. A novel stain to assist in the differentiation of benign and malignant liver lesions. Cancer 2007; 111: 316-322.
-
(2007)
Cancer
, vol.111
, pp. 316-322
-
-
Kandil, D.1
Leiman, G.2
Allegretta, M.3
Trotman, W.4
Pantanowitz, L.5
Goulart, R.6
Evans, M.7
-
8
-
-
0032934258
-
Identification of receptor ligands with phage display peptide libraries
-
Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R. Identification of receptor ligands with phage display peptide libraries. J. Nucl. Med. 1999; 40: 883-888.
-
(1999)
J. Nucl. Med.
, vol.40
, pp. 883-888
-
-
Koivunen, E.1
Arap, W.2
Rajotte, D.3
Lahdenranta, J.4
Pasqualini, R.5
-
9
-
-
78349305716
-
Targeted nanoagents for the detection of cancers
-
McCarthy JR, Bhaumik J, Karver MR, Sibel Erdem S, Weissleder R. Targeted nanoagents for the detection of cancers. Mol. Oncol. 2010; 4: 511-528.
-
(2010)
Mol. Oncol.
, vol.4
, pp. 511-528
-
-
McCarthy, J.R.1
Bhaumik, J.2
Karver, M.R.3
Sibel Erdem, S.4
Weissleder, R.5
-
10
-
-
57049157619
-
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
-
Nakano K, Orita T, Nezu J, Yoshino T, Ohizumi I, Sugimoto M, Furugaki K, Kinoshita Y, Ishiguro T, Hamakubo T, Kodama T, Aburatani H, Yamada-Okabe H, Tsuchiya M. Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 2009; 378: 279-284.
-
(2009)
Biochem. Biophys. Res. Commun.
, vol.378
, pp. 279-284
-
-
Nakano, K.1
Orita, T.2
Nezu, J.3
Yoshino, T.4
Ohizumi, I.5
Sugimoto, M.6
Furugaki, K.7
Kinoshita, Y.8
Ishiguro, T.9
Hamakubo, T.10
Kodama, T.11
Aburatani, H.12
Yamada-Okabe, H.13
Tsuchiya, M.14
-
11
-
-
78650069449
-
Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization
-
Nakano K, Ishiguro T, Konishi H, Tanaka M, Sugimoto M, Sugo I, Igawa T, Tsunoda H, Kinoshita Y, Habu K, Orita T, Tsuchiya M, Hattori K, Yamada-Okabe H. Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization. Anticancer Drugs 2010; 21: 907-916.
-
(2010)
Anticancer Drugs
, vol.21
, pp. 907-916
-
-
Nakano, K.1
Ishiguro, T.2
Konishi, H.3
Tanaka, M.4
Sugimoto, M.5
Sugo, I.6
Igawa, T.7
Tsunoda, H.8
Kinoshita, Y.9
Habu, K.10
Orita, T.11
Tsuchiya, M.12
Hattori, K.13
Yamada-Okabe, H.14
-
12
-
-
84855209928
-
Peptide heterodimers for molecular imaging
-
DOI: 10.1007/s00726-010-0546-y
-
Yan Y, Chen X. Peptide heterodimers for molecular imaging. Amino Acids 2010; DOI: 10.1007/s00726-010-0546-y.
-
(2010)
Amino Acids
-
-
Yan, Y.1
Chen, X.2
-
13
-
-
33748523141
-
Oncofetal protein glypican-3 in testicular germ-cell tumor
-
Ota S, Hishinuma M, Yamauchi N, Goto A, Morikawa T, Fujimura T, Kitamura T, Kodama T, Aburatani H, Fukayama M. Oncofetal protein glypican-3 in testicular germ-cell tumor. Virchows Arch. 2006; 449: 308-314.
-
(2006)
Virchows Arch.
, vol.449
, pp. 308-314
-
-
Ota, S.1
Hishinuma, M.2
Yamauchi, N.3
Goto, A.4
Morikawa, T.5
Fujimura, T.6
Kitamura, T.7
Kodama, T.8
Aburatani, H.9
Fukayama, M.10
-
14
-
-
33847713326
-
Radiolabeled peptides and proteins in cancer therapy
-
Wangler C, Buchmann I, Eisenhut M, Haberkorn U, Mier W. Radiolabeled peptides and proteins in cancer therapy. Protein Pept. Lett. 2007; 14: 273-279.
-
(2007)
Protein Pept. Lett.
, vol.14
, pp. 273-279
-
-
Wangler, C.1
Buchmann, I.2
Eisenhut, M.3
Haberkorn, U.4
Mier, W.5
-
15
-
-
53349177489
-
Biomarkers for the lung cancer diagnosis and their advances in proteomics
-
Sung HJ, Cho JY. Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep. 2008; 41: 615-625.
-
(2008)
BMB Rep.
, vol.41
, pp. 615-625
-
-
Sung, H.J.1
Cho, J.Y.2
-
17
-
-
43249088881
-
Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy
-
de Visser M, Verwijnen SM, de Jong M. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy. Cancer Biother. Radiopharm. 2008; 23: 137-157.
-
(2008)
Cancer Biother. Radiopharm.
, vol.23
, pp. 137-157
-
-
de Visser, M.1
Verwijnen, S.M.2
de Jong, M.3
-
18
-
-
33947389680
-
Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain
-
Hesse A, Kosmides D, Kontermann RE, Nettelbeck DM. Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain. J. Virol. 2007; 81: 2688-2699.
-
(2007)
J. Virol.
, vol.81
, pp. 2688-2699
-
-
Hesse, A.1
Kosmides, D.2
Kontermann, R.E.3
Nettelbeck, D.M.4
-
19
-
-
41649083838
-
Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals
-
Khan IU, Beck-Sickinger AG. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals. Anticancer Agents Med Chem. 2008; 8: 186-199.
-
(2008)
Anticancer Agents Med Chem.
, vol.8
, pp. 186-199
-
-
Khan, I.U.1
Beck-Sickinger, A.G.2
-
20
-
-
34548168881
-
Tumour-homing peptides: tools for targeting, imaging and destruction
-
Enback J, Laakkonen P. Tumour-homing peptides: tools for targeting, imaging and destruction. Biochem. Soc. Trans. 2007; 35: 780-783.
-
(2007)
Biochem. Soc. Trans.
, vol.35
, pp. 780-783
-
-
Enback, J.1
Laakkonen, P.2
-
21
-
-
47249121391
-
KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases
-
Bayon Y, Trinidad AG, de la Puerta ML, Del Carmen Rodriguez M, Bogetz J, Rojas A, De Pereda JM, Rahmouni S, Williams S, Matsuzawa S, Reed JC, Crespo MS, Mustelin T, Alonso A. KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases. FEBS J. 2008; 275: 3900-3910.
-
(2008)
FEBS J.
, vol.275
, pp. 3900-3910
-
-
Bayon, Y.1
Trinidad, A.G.2
de la Puerta, M.L.3
Del Rodriguez, M.4
Bogetz, J.5
Rojas, A.6
De Pereda, J.M.7
Rahmouni, S.8
Williams, S.9
Matsuzawa, S.10
Reed, J.C.11
Crespo, M.S.12
Mustelin, T.13
Alonso, A.14
-
22
-
-
55849131053
-
Update: molecular radiotherapy: survey and current status
-
Sgouros G. Update: molecular radiotherapy: survey and current status. Cancer Biother. Radiopharm. 2008; 23: 531-540.
-
(2008)
Cancer Biother. Radiopharm.
, vol.23
, pp. 531-540
-
-
Sgouros, G.1
-
23
-
-
17644401029
-
Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma
-
Nakatsura T, Nishimura Y. Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma. BioDrugs 2005; 19:71-77.
-
(2005)
BioDrugs
, vol.19
, pp. 71-77
-
-
Nakatsura, T.1
Nishimura, Y.2
|